Effects of Sodium–Glucose Cotransporter 2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer
The use of SGLT2is does not negatively impact the 1-year amputation rate or healing rate of DFU. One-year mortality was lower in patients treated with an SGLT2i.
Authors
- C. Fourmont
- Alexia Rouland (ORCID: https://orcid.org/0000-0003-0727-2052)
- B Vergès
- Claire Dumortier (ORCID: https://orcid.org/0009-0000-7293-1742)
- Benjamin Bouillet (ORCID: https://orcid.org/0000-0002-4317-6714)
- Lina Houbachi
- Jean Michel Petit
- Serge Aho Glélé
Institutions
- Inserm (FR)
- Université de Bourgogne (FR)
- CHU Dijon Bourgogne (FR)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-02-25
- DOI
- https://doi.org/10.2337/dc25-2001
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00